Crystalline form of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin -5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate

Details for Australian Patent Application No. 2010210627 (hide)

Owner Trius Therapeutics Reichenbacher, K. Simson, J. Duguid, R.

Inventors Phillipson, Douglas

Agent Madderns

Pub. Number AU-A-2010210627

PCT Pub. Number WO2010/091131

Priority 61/149,402 03.02.09 US

Filing date 3 February 2010

Wipo publication date 12 August 2010

International Classifications

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

25 August 2011 PCT application entered the National Phase

  PCT publication WO2010/091131 Priority application(s): WO2010/091131

29 September 2011 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read Reichenbacher, Katharina; Duguid, Robert J.; Simson, Jacqueline A. and Phillipson, Douglas

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010210636-Treatment of lung cancer with a nitrobenzamide compound in combination with a growth factor inhibitor

2010210620-Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications